Results 311 to 320 of about 280,195 (357)

An Autopsy Case of Bronchiolitis Obliterans Associated With Oral Lichen Planus and Non-Hodgkin Lymphoma. [PDF]

Cureus
Kurashina K, Hokari S, Koizumi T, Shibata S, Tomiyama K, Hashidate H, Tsukada H, Kikuchi T.   +7 more
europepmc   +1 more source

Preemptive Rituximab for Epstein–Barr Virus Reactivation after Hematopoietic Cell Transplantation: Necessary for All?

Transplant Infectious Disease, EarlyView.
A sudden increase in EBV DNAemia appears to be a better predictor of PTLD and EBV end‐organ disease than persistent and stable levels of EBV DNAemia. Most HCT recipients with EBV DNAemia did not require rituximab, and immunosuppression reduction was sufficient to control most episodes of EBV reactivation.
Anna Beatriz Coelho de Souza, Anderson João Simione, Ana Cláudia Ferrari dos Santos, Iago Colturato, Fernanda Rodrigues Barbieri, Juliana Ribeiro do Prado Moreno, Lilian Perílio Zanetti, Leila Cibele Serra de Oliveira, Erika Rodrigues Pontes Delattre, Juliana Silva Santos, Mair Pedro de Souza, Vergílio A. R. Colturato, Clarisse M. Machado   +12 more
wiley   +1 more source

Comprehensive investigation of cuproptosis-related genes in clinical features, biological characteristics, and immune microenvironment in B-cell Non-Hodgkin lymphoma. [PDF]

J Transl Int Med
Liu C, Shao R, Li X, Li Y, Tian Z, Zhou F, Chen L, Liu J, Chang B, Liu W, Tang H.   +10 more
europepmc   +1 more source

Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey, Paul R. Hess, Joanne L. Intile   +2 more
wiley   +1 more source

Autoimmune Diseases and Risk of Non-Hodgkin Lymphoma: A Mendelian Randomisation Study. [PDF]

Cancer Med
Shi X, Wallach JD, Ma X, Rogne T.
europepmc   +1 more source

Artificial Intelligence in Veterinary Clinical Pathology—An Introduction and Review

Veterinary Clinical Pathology, EarlyView.
ABSTRACT Artificial intelligence (AI), particularly through machine learning and deep learning, presents opportunities for the enhancement of the workflow of the veterinary clinical pathologist. This review introduces basic concepts in AI in a nontechnical manner and explores the qualification and integration of AI in veterinary clinical pathology. The
Samuel V. Neal, Daniel G. Rudmann, Kara N. Corps   +2 more
wiley   +1 more source

Trends and projections of Non-Hodgkin lymphoma burden (1990-2040): a global burden of disease 2021 analysis. [PDF]

BMC Public Health
Wang S, Zhou H, Liu Y, Li Y, Nie L.
europepmc   +1 more source

A Rare Case of Non-Hodgkin Lymphoma Presenting as a Penile Mass [PDF]

Turk J Haematol
Sevinç AH, Teke İ, Hürdoğan Ö, Altay A, Cantürk Z, Dursun M, Kadıoğlu A.   +6 more
europepmc   +1 more source

Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial. [PDF]

Ann Hematol
Dührsen U, Prange-Krex G, Moeller R, Held H, Heil G, Schwarzer A, Mahlmann S, Dienst A, Sandmann M, Maschmeyer G, Schütte J, Hahn D, Heike M, Nonnemacher M, Hanoun C, Hüttmann A, PETAL trial investigators.   +16 more
europepmc   +1 more source

A Rare Case of Non-Hodgkin Lymphoma With Ankle Involvement: Diagnostic and Therapeutic Challenges. [PDF]

Cureus
Celayir A, Afacan MY, Sevgil B, Ozsahin MK, Botanlioglu H.   +4 more
europepmc   +1 more source